Literature DB >> 8158049

Phenotypic and genotypic changes in a new clone complex of Neisseria meningitidis causing disease in The Netherlands, 1958-1990.

R J Scholten1, J T Poolman, H A Valkenburg, H A Bijlmer, J Dankert, D A Caugant.   

Abstract

To characterize the phenotypic and genotypic changes that occurred in a new clone lineage of Neisseria meningitidis (lineage III) in the Netherlands, the electrophoretic type (ET) was determined for 79 serogroup B isolates of serotype 4 or subtype P1.4 (or both) obtained between 1958 and 1990 from patients with systemic meningococcal disease. Thirty-five previously described isolates were also included. After its appearance in 1980, lineage III started homogeneously with regard to both genotype (ET-24) and phenotype (B:4:P1.4). After 1984, other clones appeared in the lineage, and the various clones acquired other serotypes (serotypes 14 and 15) and subtypes (P1.2, P1.7, and P1.12), indicating frequent exchange of genetic material between clones. These results indicate that basing a serogroup B vaccine on outer membrane components from a single strain is not a valid strategy for the prevention of meningococcal disease.

Entities:  

Mesh:

Year:  1994        PMID: 8158049     DOI: 10.1093/infdis/169.3.673

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Sequence variation in the porB gene from B:P1.4 meningococci causing New Zealand's epidemic.

Authors:  Kristin H Dyet; Diana R Martin
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

2.  Clonal analysis of the serogroup B meningococci causing New Zealand's epidemic.

Authors:  K H Dyet; D R Martin
Journal:  Epidemiol Infect       Date:  2006-04       Impact factor: 2.451

3.  Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B.

Authors:  M Van Looveren; P Vandamme; M Hauchecorne; M Wijdooghe; F Carion; D A Caugant; H Goossens
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms.

Authors:  M C Maiden; J A Bygraves; E Feil; G Morelli; J E Russell; R Urwin; Q Zhang; J Zhou; K Zurth; D A Caugant; I M Feavers; M Achtman; B G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  Antigenic variation of the class I outer membrane protein in hyperendemic Neisseria meningitidis strains in the netherlands.

Authors:  A Bart; J Dankert; A van der Ende
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

7.  Standardization of Neisseria meningitidis serogroup B colorimetric serum bactericidal assay.

Authors:  Tamara Rodríguez; Miriam Lastre; Barbara Cedré; Judith del Campo; Gustavo Bracho; Caridad Zayas; Carlos Taboada; Miriam Díaz; Gustavo Sierra; Oliver Pérez
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

8.  eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data.

Authors:  Edward J Feil; Bao C Li; David M Aanensen; William P Hanage; Brian G Spratt
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

9.  Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.

Authors:  Yanet Climent; Daniel Yero; Isabel Martinez; Alejandro Martín; Keith A Jolley; Franklin Sotolongo; Martin C J Maiden; Rachel Urwin; Rolando Pajón
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

10.  Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients.

Authors:  C A Fijen; E J Kuijper; J Dankert; M R Daha; D A Caugant
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.